Welcome to our dedicated page for QT Imaging Holdings SEC filings (Ticker: QTIWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on QT Imaging Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into QT Imaging Holdings's regulatory disclosures and financial reporting.
QT Imaging Holdings, Inc. completed an underwritten public offering of 1,200,000 common shares and 800,000 pre-funded warrants for gross proceeds of $10 million, generating estimated net proceeds of about $9 million. The common shares were priced at $5.00 per share and the pre-funded warrants at $4.9999 each, with a nominal exercise price of $0.0001 per warrant share. All securities were sold by the company under an effective Form S-3 shelf registration, and the deal closed on May 18, 2026. The company plans to use the funds for working capital and general corporate purposes. Officers, directors and certain stockholders agreed to 90-day lock-ups, while the company agreed to 60-day restrictions on new equity issuance and a 180-day ban on variable rate transactions, subject to specified exceptions.
QT Imaging Holdings, Inc. completed an underwritten public offering of 1,200,000 common shares and 800,000 pre-funded warrants for gross proceeds of $10 million, generating estimated net proceeds of about $9 million. The common shares were priced at $5.00 per share and the pre-funded warrants at $4.9999 each, with a nominal exercise price of $0.0001 per warrant share. All securities were sold by the company under an effective Form S-3 shelf registration, and the deal closed on May 18, 2026. The company plans to use the funds for working capital and general corporate purposes. Officers, directors and certain stockholders agreed to 90-day lock-ups, while the company agreed to 60-day restrictions on new equity issuance and a 180-day ban on variable rate transactions, subject to specified exceptions.
QT Imaging Holdings is offering $9,999,920 of securities consisting of 1,200,000 shares of common stock and pre-funded warrants to purchase up to 800,000 shares of common stock.
The public offering price is $5.00 per share (pre-funded warrant price equals share price minus $0.0001). Underwriting discounts total $699,994.40, and estimated net proceeds to the company are approximately $9.0 million before expenses. The company reported 12,042,500 shares outstanding as of May 14, 2026, and would have approximately 13,242,500 shares outstanding after the offering assuming none of the pre-funded warrants are exercised.
QT Imaging Holdings is offering $9,999,920 of securities consisting of 1,200,000 shares of common stock and pre-funded warrants to purchase up to 800,000 shares of common stock.
The public offering price is $5.00 per share (pre-funded warrant price equals share price minus $0.0001). Underwriting discounts total $699,994.40, and estimated net proceeds to the company are approximately $9.0 million before expenses. The company reported 12,042,500 shares outstanding as of May 14, 2026, and would have approximately 13,242,500 shares outstanding after the offering assuming none of the pre-funded warrants are exercised.
QT Imaging Holdings, Inc. reported sharply higher revenue and a smaller loss for the quarter ended March 31, 2026. Revenue rose to $6.5 million from $2.8 million a year earlier, driven almost entirely by product sales in the United States.
Gross profit increased to $2.7 million, but higher research and development plus selling, general and administrative expenses pushed the operating loss to $2.3 million. Net loss narrowed to $3.4 million from $11.1 million, helped by lower other expenses.
Cash and cash equivalents were $6.9 million, with cash used in operating activities of $3.7 million in the quarter. Total liabilities were $18.2 million and stockholders’ equity fell to $3.8 million from $6.4 million, reflecting ongoing losses and fair value changes in warrant and earnout liabilities.
The company highlighted distribution agreements with minimum order quantities that it believes, together with the Lynrock Lake Term Loan (now maturing in 2029 at 12% interest), PIPE financings, and expected MOQ-related revenue, will fund its operating plan for at least the next 12 months.
QT Imaging Holdings, Inc. reported sharply higher revenue and a smaller loss for the quarter ended March 31, 2026. Revenue rose to $6.5 million from $2.8 million a year earlier, driven almost entirely by product sales in the United States.
Gross profit increased to $2.7 million, but higher research and development plus selling, general and administrative expenses pushed the operating loss to $2.3 million. Net loss narrowed to $3.4 million from $11.1 million, helped by lower other expenses.
Cash and cash equivalents were $6.9 million, with cash used in operating activities of $3.7 million in the quarter. Total liabilities were $18.2 million and stockholders’ equity fell to $3.8 million from $6.4 million, reflecting ongoing losses and fair value changes in warrant and earnout liabilities.
The company highlighted distribution agreements with minimum order quantities that it believes, together with the Lynrock Lake Term Loan (now maturing in 2029 at 12% interest), PIPE financings, and expected MOQ-related revenue, will fund its operating plan for at least the next 12 months.
QT Imaging Holdings reported strong first quarter 2026 growth, with revenue of $6.5 million, up 133% from $2.8 million a year earlier, driven by shipments of 13 Breast Acoustic CT scanners versus six in the prior-year period.
Gross margin was 41% compared with 65%, reflecting mix effects, while operating expenses rose to $5.0 million from $2.9 million, leading to a net loss of $3.4 million, a notable improvement from $11.1 million. Cash, restricted cash, and cash equivalents were $7.0 million as of March 31, 2026.
The company extended the maturity of its senior secured term loan to March 31, 2029 and increased the interest rate to 12.0% per annum. It also secured a dedicated Category III CPT code effective January 1, 2027, obtained FDA 510(k) clearance for scanner enhancements, and reaffirmed 2026 revenue guidance of approximately $39 million supported by minimum order commitments and a multiyear UAE distribution agreement totaling more than $24 million in scanner revenue.
QT Imaging Holdings reported strong first quarter 2026 growth, with revenue of $6.5 million, up 133% from $2.8 million a year earlier, driven by shipments of 13 Breast Acoustic CT scanners versus six in the prior-year period.
Gross margin was 41% compared with 65%, reflecting mix effects, while operating expenses rose to $5.0 million from $2.9 million, leading to a net loss of $3.4 million, a notable improvement from $11.1 million. Cash, restricted cash, and cash equivalents were $7.0 million as of March 31, 2026.
The company extended the maturity of its senior secured term loan to March 31, 2029 and increased the interest rate to 12.0% per annum. It also secured a dedicated Category III CPT code effective January 1, 2027, obtained FDA 510(k) clearance for scanner enhancements, and reaffirmed 2026 revenue guidance of approximately $39 million supported by minimum order commitments and a multiyear UAE distribution agreement totaling more than $24 million in scanner revenue.
QT Imaging Holdings, Inc. Schedule 13G/A shows Alta Partners LLC reports beneficial ownership of 540,842 shares of Common Stock, representing 4.3% of the class; these shares are described as issuable upon exercise of warrants. The filing is signed by Steven Cohen as Managing Member on 05/08/2026.
QT Imaging Holdings, Inc. Schedule 13G/A shows Alta Partners LLC reports beneficial ownership of 540,842 shares of Common Stock, representing 4.3% of the class; these shares are described as issuable upon exercise of warrants. The filing is signed by Steven Cohen as Managing Member on 05/08/2026.
QT Imaging Holdings, Inc. updated compensation for its top executives. The Board increased Chief Executive Officer Dr. Raluca Dinu’s annual base salary from $550,000 to $605,000, effective March 20, 2026, and approved a cash bonus of $231,993 for her.
Chief Financial Officer Jay Jennings received a cash bonus of $40,576. The Board also granted Dr. Dinu a total of 519,500 restricted stock units (RSUs), split into grants of 3,500, 16,000 and 500,000 RSUs, vesting in scheduled installments from May 15, 2026 through February 15, 2030, contingent on continued service.
Mr. Jennings received a grant of 2,800 RSUs, with 933 RSUs vesting on May 15, 2027 and the remaining 1,867 RSUs vesting in eight quarterly installments through May 15, 2029, also subject to his continued service with the company.
QT Imaging Holdings, Inc. updated compensation for its top executives. The Board increased Chief Executive Officer Dr. Raluca Dinu’s annual base salary from $550,000 to $605,000, effective March 20, 2026, and approved a cash bonus of $231,993 for her.
Chief Financial Officer Jay Jennings received a cash bonus of $40,576. The Board also granted Dr. Dinu a total of 519,500 restricted stock units (RSUs), split into grants of 3,500, 16,000 and 500,000 RSUs, vesting in scheduled installments from May 15, 2026 through February 15, 2030, contingent on continued service.
Mr. Jennings received a grant of 2,800 RSUs, with 933 RSUs vesting on May 15, 2027 and the remaining 1,867 RSUs vesting in eight quarterly installments through May 15, 2029, also subject to his continued service with the company.
QT Imaging Holdings, Inc. files its annual report describing a breast imaging business built around its QT Breast Scanner, a 3D ultrasound tomography system that avoids ionizing radiation and breast compression. The device received initial FDA 510(k) clearance in June 2017, an additional quantitative breast density clearance in August 2022, and a further clearance on March 10, 2026 for an enhanced configuration that improves imaging of posterior breast tissue near the chest wall.
The company outlines a strategy to evolve from a hardware maker into a precision imaging platform by adding a cloud SaaS infrastructure and future AI modules for quantitative biomarkers and diagnostic decision support. It targets the breast imaging market, which the report cites at about $6.04 billion globally in 2025, and references broader medical imaging and cancer screening markets. Commercially, QT Imaging has an exclusive U.S. distribution agreement with NXC Imaging, tied to minimum order quantities, and exclusive distribution deals with Gulf Medical Co. in Saudi Arabia and Al Naghi Medical Co. in the UAE. The Al Naghi agreement includes minimum orders totaling 43 scanners from 2026 through 2028, representing more than $24 million in revenue commitments, subject to performance and supply conditions.
QT Imaging Holdings, Inc. files its annual report describing a breast imaging business built around its QT Breast Scanner, a 3D ultrasound tomography system that avoids ionizing radiation and breast compression. The device received initial FDA 510(k) clearance in June 2017, an additional quantitative breast density clearance in August 2022, and a further clearance on March 10, 2026 for an enhanced configuration that improves imaging of posterior breast tissue near the chest wall.
The company outlines a strategy to evolve from a hardware maker into a precision imaging platform by adding a cloud SaaS infrastructure and future AI modules for quantitative biomarkers and diagnostic decision support. It targets the breast imaging market, which the report cites at about $6.04 billion globally in 2025, and references broader medical imaging and cancer screening markets. Commercially, QT Imaging has an exclusive U.S. distribution agreement with NXC Imaging, tied to minimum order quantities, and exclusive distribution deals with Gulf Medical Co. in Saudi Arabia and Al Naghi Medical Co. in the UAE. The Al Naghi agreement includes minimum orders totaling 43 scanners from 2026 through 2028, representing more than $24 million in revenue commitments, subject to performance and supply conditions.
Taylor Ross reported acquisition or exercise transactions in this Form 4 filing.
QT Imaging Holdings director Taylor Ross received an equity grant of 3,500 shares of Common Stock on March 20, 2026, at no cash cost. Following this award, Ross directly holds 60,578 shares. The grant is in the form of Restricted Stock Units that vest in four equal installments on May 15, 2026, August 15, 2026, November 15, 2026, and February 15, 2027, subject to continued service. All units vest immediately if there is a Change of Control under the company’s 2024 Equity Incentive Plan.
Taylor Ross reported acquisition or exercise transactions in this Form 4 filing.
QT Imaging Holdings director Taylor Ross received an equity grant of 3,500 shares of Common Stock on March 20, 2026, at no cash cost. Following this award, Ross directly holds 60,578 shares. The grant is in the form of Restricted Stock Units that vest in four equal installments on May 15, 2026, August 15, 2026, November 15, 2026, and February 15, 2027, subject to continued service. All units vest immediately if there is a Change of Control under the company’s 2024 Equity Incentive Plan.
GREENE JAMES S reported acquisition or exercise transactions in this Form 4 filing.
QT IMAGING HOLDINGS, INC. director James S. Greene reported an equity award of 3,500 shares of Common Stock, bringing his direct holdings to 3,500 shares. The award is structured as Restricted Stock Units that vest 25% on each of May 15, 2026, August 15, 2026, November 15, 2026, and February 15, 2027, subject to his continued service. All RSUs will fully vest immediately if there is a Change of Control as defined in the company’s 2024 Equity Incentive Plan.
GREENE JAMES S reported acquisition or exercise transactions in this Form 4 filing.
QT IMAGING HOLDINGS, INC. director James S. Greene reported an equity award of 3,500 shares of Common Stock, bringing his direct holdings to 3,500 shares. The award is structured as Restricted Stock Units that vest 25% on each of May 15, 2026, August 15, 2026, November 15, 2026, and February 15, 2027, subject to his continued service. All RSUs will fully vest immediately if there is a Change of Control as defined in the company’s 2024 Equity Incentive Plan.
Jennings Jay Walter reported acquisition or exercise transactions in this Form 4 filing.
QT Imaging Holdings, Inc. reported that Chief Financial Officer Jay Walter Jennings received a grant of 2,800 shares of common stock on March 20, 2026 as a stock award. The grant price per share was $0.00, and his direct holdings after the award total 2,800 shares.
According to the vesting schedule, one-third of the related restricted stock units vest on May 15, 2027, with the remaining two-thirds vesting in eight equal quarterly installments on each subsequent August 15, November 15, February 15, and May 15, so that the grant is fully vested on May 15, 2029. All such units will immediately vest if there is a Change of Control as defined in the company’s 2024 Equity Incentive Plan.
Jennings Jay Walter reported acquisition or exercise transactions in this Form 4 filing.
QT Imaging Holdings, Inc. reported that Chief Financial Officer Jay Walter Jennings received a grant of 2,800 shares of common stock on March 20, 2026 as a stock award. The grant price per share was $0.00, and his direct holdings after the award total 2,800 shares.
According to the vesting schedule, one-third of the related restricted stock units vest on May 15, 2027, with the remaining two-thirds vesting in eight equal quarterly installments on each subsequent August 15, November 15, February 15, and May 15, so that the grant is fully vested on May 15, 2029. All such units will immediately vest if there is a Change of Control as defined in the company’s 2024 Equity Incentive Plan.